Finally, Yang, et al., demonstrated improved survival in a murine orthotopic model of disseminated ovarian cancer with treatment with a conditionally replicating adenovirus expressing TIMP2, an inhibitor of MMP9 [35]. Here, TIMP2 is linked to ovarian cancer.